Paul Tudor Jones’s HOOKIPA Pharma HOOK Stock Holding History

Paul Tudor Jones’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,000	Closed	-$222K	–	1691
2020 Q4	$222K	Buy	+2,000	New	+$216K	0.01%	1208

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Paul Tudor Jones's HOOK Position: Q1 2021 in Review

Paul Tudor Jones sold out of HOOKIPA Pharma (HOOK) in Q1 2021, closing a stake of 2,000 shares — an estimated $222K sold.

Paul Tudor Jones first reported a position in HOOK in Q4 2020 and held it in 1 quarter. The position peaked at $222K in Q4 2020. 62 funds tracked by Wall St. Rank hold HOOK as of Q1 2021.

Paul Tudor Jones reported no remaining HOOKIPA Pharma position as of Q1 2021 after selling out during the quarter.
Paul Tudor Jones sold 2,000 HOOKIPA Pharma shares in Q1 2021, an estimated $222K.
Paul Tudor Jones first reported a position in HOOKIPA Pharma in Q4 2020 and held it in 1 quarter.
Paul Tudor Jones's HOOKIPA Pharma position peaked at $222K in Q4 2020.
62 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2021.

Based on Tudor Investment Corp's 13F filing for Q1 2021, filed 17 May 2021.